logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Pneumonia

    FiltersReset Filters
    17 results

    • cefepime

      (Cefepime)
      Apotex Corp.
      Usage: Cefepime for Injection is indicated for treating moderate to severe pneumonia, febrile neutropenia, uncomplicated and complicated urinary tract infections, uncomplicated skin infections, and complicated intra-abdominal infections (with metronidazole). It should be used when infections are proven or suspected to be caused by susceptible bacteria.

    • cleocin phosphate

      (clindamycin phosphate)
      Pharmacia & Upjohn Company LLC
      Usage: CLEOCIN PHOSPHATE is indicated for serious infections caused by susceptible anaerobic bacteria, streptococci, pneumococci, and staphylococci, particularly in penicillin-allergic individuals. It treats lower respiratory, skin, gynecological, intra-abdominal, septicemia, and bone/joint infections. Use alongside surgical procedures is recommended, with caution due to potential colitis risks.

    • clindamycin phosphate

      (Clindamycin phosphate)
      Baxter Healthcare Corporation
      Usage: Clindamycin Injection USP in 5% Dextrose is indicated for serious infections caused by susceptible anaerobic bacteria and certain streptococci, pneumococci, and staphylococci. It is primarily reserved for penicillin-allergic patients and is used for respiratory, skin, gynecological, intra-abdominal, septicemia, and bone/joint infections.

    • dexamethasone sodium phosphate

      (Dexamethasone Sodium Phosphate)
      Somerset Therapeutics, LLC
      Usage: This drug is indicated for intravenous or intramuscular use in endocrine disorders, rheumatic disorders, collagen diseases, dermatologic conditions, severe allergic states, ophthalmic diseases, gastrointestinal and respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, and acute exacerbations of multiple sclerosis, among other conditions.

    • erythromycin

      (Erythromycin)
      Teva Pharmaceuticals USA, Inc.
      Usage: Erythromycin tablets are indicated for treating infections from susceptible bacteria, including upper and lower respiratory tract infections, listeriosis, pertussis, diphtheria, and skin infections. It may also be used for prophylaxis of rheumatic fever in penicillin-allergic patients, and to treat various chlamydial infections and primary syphilis.

    • fluconazole

      (Fluconazole)
      Sagent Pharmaceuticals
      Usage: Fluconazole in Sodium Chloride Injection is indicated for treating oropharyngeal and esophageal candidiasis, cryptococcal meningitis, and for prophylaxis against candidiasis in patients undergoing bone marrow transplantation. It is effective in various Candida infections, with therapy adjusted based on culture results when available.

    • fluconazole

      (Fluconazole)
      NorthStar RxLLC
      Usage: Fluconazole for oral suspension is indicated for treating oropharyngeal and esophageal candidiasis, cryptococcal meningitis in AIDS patients, and for prophylaxis against candidiasis in bone marrow transplant patients undergoing chemotherapy or radiation. It may also be effective for various Candida infections, including urinary tract infections and candidemia.

    • fluconazole

      (fluconazole)
      Greenstone LLC
      Usage: Fluconazole is indicated for the treatment of vaginal candidiasis, oropharyngeal and esophageal candidiasis, cryptococcal meningitis, and systemic Candida infections. It is also used prophylactically to reduce candidiasis incidence in patients undergoing bone marrow transplantation with cytotoxic chemotherapy or radiation therapy.

    • fluconazole

      (Fluconazole)
      Zhejiang Poly Pharm. Co., Ltd.
      Usage: Fluconazole for oral suspension is indicated for treating oropharyngeal and esophageal candidiasis, cryptococcal meningitis, and reducing candidiasis incidence in patients undergoing bone marrow transplantation. It is also effective for Candida urinary tract infections and systemic infections, though culture tests should guide therapy adjustments.

    • penicillin g potassium

      (penicillin g potassium)
      Sagent Pharmaceuticals
      Usage: Penicillin G Potassium for Injection is indicated for serious infections caused by susceptible microorganisms, including septicemia, pneumonia, meningitis, and various bacterial infections such as anthrax, syphilis, and diphtheria. It should be administered based on culture results or strong suspicion of infection by targeted organisms.